| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 0.9 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.0062 | 1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.01 | 1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |